Advertisement

Autism Spectrum Disorders in Tuberous Sclerosis

  • Kristina Julich
  • Mustafa SahinEmail author
Reference work entry

Abstract

Tuberous sclerosis complex (TSC) is a genetic, multisystem disorder that affects the skin, kidneys, heart, and lungs, and, in the vast majority of cases, the brain. It is caused by mutations of either the TSC1 or TSC2 gene. These genes function as inhibitors of the mTOR Complex 1 (mTORC1) pathway, a master regulator in the cell that integrates growth factor, energy, and nutrient signals to control cellular growth and protein translation. The TSC/mTORC1 pathway is also involved in various steps of neuronal development and maturation, such as neuronal polarization, axon guidance, synaptic plasticity, and myelination. A loss-of-function mutation in either of the TSC genes results in constitutive overactivation of mTORC1 and a loss of control over downstream events.

Neurological symptoms of TSC can include epilepsy, cognitive disabilities, and behavioral abnormalities such as attention deficit hyperactivity disorder (ADHD), autism, and autism spectrum disorders (ASD). About 50 % of TSC patients are diagnosed with ASD, with a male-to-female ratio of 1:1. How TSC causes this phenomenon is not yet clear. It was originally thought that the benign hamartomas called cortical tubers were responsible for autism and other neurological symptoms of this disorder. However, research from the past decade, including rodent models with learning deficits and abnormal social approach behavior in the absence of a tuber-like brain pathology, indicates that microstructural abnormalities such as axon connectivity and myelination, as well as altered glutamate and GABAergic neurotransmission, render individuals with TSC highly susceptible to autism.

Keywords

Autism Spectrum Disorder Autism Spectrum Disorder Attention Deficit Hyperactivity Disorder Diffusion Tensor Imaging Tuberous Sclerosis Complex 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Au KS, Northrup H. Genotype-phenotype studies in TSC and molecular diagnostics. In: Kwiatkowski DJ, Whittemore VH, Thiele EA, editors. Tuberous sclerosis complex. 1st ed. Weinheim: Wiley-VCH; 2010. p. 61–84.CrossRefGoogle Scholar
  2. Bolton PF, Park RJ, Higgins JN, et al. Neuro-epileptic determinants of autism spectrum disorders in tuberous sclerosis complex. Brain. 2002;125:1247–55.PubMedCrossRefGoogle Scholar
  3. Bourneville DM, Brissaud E. Encéphalite ou sclérose tubéreuse des circonvolutions cérébrales. Arch Neurol. 1881;1:390–412.Google Scholar
  4. Choi YJ, Di Nardo A, Kramvis I, et al. Tuberous sclerosis complex proteins control axon formation. Genes Dev. 2008;22:2485–95.PubMedCrossRefGoogle Scholar
  5. Crino PB. Molecular pathogenesis of tuber formation in tuberous sclerosis complex. J Child Neurol. 2004;19:716–25.PubMedGoogle Scholar
  6. Curatolo P, Napolioni V, Moavero R. Autism spectrum disorders in tuberous sclerosis: pathogenetic pathways and implications for treatment. J Child Neurol. 2010;25:873–80.PubMedCrossRefGoogle Scholar
  7. de Vries PJ, Howe CJ. The tuberous sclerosis complex proteins – a GRIPP on cognition and neurodevelopment. Trends Mol Med. 2007;13:319–26.PubMedCrossRefGoogle Scholar
  8. de Vries P, Humphrey A, McCartney D, et al. Consensus clinical guidelines for the assessment of cognitive and behavioural problems in tuberous sclerosis. Eur Child Adolesc Psychiatry. 2005;14:183–90.PubMedCrossRefGoogle Scholar
  9. Ehninger D, Silva AJ. Rapamycin for treating tuberous sclerosis and autism spectrum disorders. Trends Mol Med. 2011;17:78–87.PubMedCrossRefGoogle Scholar
  10. Ehninger D, Han S, Shilyansky C, et al. Reversal of learning deficits in a Tsc2+/− mouse model of tuberous sclerosis. Nat Med. 2008;14:843–8.PubMedCrossRefGoogle Scholar
  11. Eluvathingal TJ, Behen ME, Chugani HT, et al. Cerebellar lesions in tuberous sclerosis complex: neurobehavioral and neuroimaging correlates. J Child Neurol. 2006;21:846–51.PubMedCrossRefGoogle Scholar
  12. Ess KC. Tuberous sclerosis complex: everything old is new again. J Neurodev Disord. 2009;1:141–9.PubMedCrossRefGoogle Scholar
  13. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell. 1993;75:1305–15.CrossRefGoogle Scholar
  14. Fatemi SH, Aldinger KA, Ashwood P, et al. Consensus paper: pathological role of the cerebellum in autism. Cerebellum. 2012;11(3):777–807.PubMedCrossRefGoogle Scholar
  15. Goodman M, Lamm SH, Engel A, et al. Cortical tuber count: a biomarker indicating neurologic severity of tuberous sclerosis complex. J Child Neurol. 1997;12:85–90.PubMedCrossRefGoogle Scholar
  16. Goorden SM, van Woerden GM, van der Weerd L, Cheadle JP, Elgersma Y. Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures. Ann Neurol. 2007;62:648–655.PubMedCrossRefGoogle Scholar
  17. Hoeffer CA, Klann E. mTOR signaling: at the crossroads of plasticity, memory and disease. Trends Neurosci. 2010;33:67–75.PubMedCrossRefGoogle Scholar
  18. Jambaque I, Cusmai R, Curatolo P, et al. Neuropsychological aspects of tuberous sclerosis in relation to epilepsy and MRI findings. Dev Med Child Neurol. 1991;33:698–705.PubMedCrossRefGoogle Scholar
  19. Jansen FE, Vincken KL, Algra A, et al. Cognitive impairment in tuberous sclerosis complex is a multifactorial condition. Neurology. 2008;70:916–23.PubMedCrossRefGoogle Scholar
  20. Jeste SS, Sahin M, Bolton P, et al. Characterization of autism in young children with tuberous sclerosis complex. J Child Neurol. 2008;23:520–5.PubMedCrossRefGoogle Scholar
  21. Joinson C, O’Callaghan FJ, Osborne JP, et al. Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex. Psychol Med. 2003;33:335–44.PubMedCrossRefGoogle Scholar
  22. Kobayashi T, Minowa O, Kuno J, Mitani H, Hino O, Noda, T. Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res. 1999;59:206–1211.Google Scholar
  23. Kobayashi T, Minowa O, Sugitani Y, Takai S, Mitani H, Kobayashi E, Noda T, Hino O. A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc Natl Acad Sci USA. 2001;98:8762–8767.PubMedCrossRefGoogle Scholar
  24. Kohrman MH. Emerging treatments in the management of tuberous sclerosis complex. Pediatr Neurol. 2012;46:267–75.PubMedCrossRefGoogle Scholar
  25. Kwiatkowski DJ. Genetics of tuberous sclerosis complex. In: Kwiatkowski DJ, Whittemore VH, Thiele EA, editors. Tuberous sclerosis complex. 1st ed. Weinheim: Wiley-VCH; 2010. p. 29–60.CrossRefGoogle Scholar
  26. Laplante M, Sabatini DM. mTOR signaling in growth control and disease. Cell. 2012;149:274–93.PubMedCrossRefGoogle Scholar
  27. Meikle L, Talos DM, Onda H, et al. A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival. J Neurosci. 2007;27:5546–58.PubMedCrossRefGoogle Scholar
  28. Nie D, Di Nardo A, Han JM, et al. Tsc2-Rheb signaling regulates EphA-mediated axon guidance. Nat Neurosci. 2010;13:163–72.PubMedCrossRefGoogle Scholar
  29. Osborne JP, Fryer A, Webb D. Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991;615:125–7.PubMedCrossRefGoogle Scholar
  30. Paciorkowski AR, Thio LL, Dobyns WB. Genetic and biologic classification of infantile spasms. Pediatr Neurol. 2011;45:355–67.PubMedCrossRefGoogle Scholar
  31. Peça J, Feng G. Cellular and synaptic network defects in autism. Curr Opin Neurobiol. 2012;22:1–7.CrossRefGoogle Scholar
  32. Peters JM, Sahin M, Vogel-Farley VK, et al. Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex. Acad Radiol. 2012;19:17–25.PubMedCrossRefGoogle Scholar
  33. Roach ES, Sparagana SP. Diagnosis of tuberous sclerosis complex. J Child Neurol. 2004;19:643–9.PubMedGoogle Scholar
  34. Roach ES, Gomez MR, Northrup H. Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria. J Child Neurol. 1998;13:624–8.PubMedCrossRefGoogle Scholar
  35. Smalley SL. Autism and tuberous sclerosis. J Autism Dev Disord. 1998;28:407–14.PubMedCrossRefGoogle Scholar
  36. Taki MM, Harada M, Mori K, et al. High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI instrument. Neuroimage. 2009;47:1207–14.PubMedCrossRefGoogle Scholar
  37. Talos DM, Kwiatkowski DJ, Cordero K, et al. Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers. Ann Neurol. 2008;63:454–65.PubMedCrossRefGoogle Scholar
  38. Tsai P, Sahin M. Mechanisms of neurocognitive dysfunction and therapeutic considerations in tuberous sclerosis complex. Curr Opin Neurol. 2011;24:106–13.PubMedCrossRefGoogle Scholar
  39. Tsai PT, Hull C, Greene-Colozzi E, Sadowski A, Leech J, Steinberg J, Crawley JN, Regehr WG, Sahin M. Autistic behavior and cerebellar dysfunction in Purkinje cell Tsc1 mutants. Nature. 2012;488(7413)647–51.PubMedCrossRefGoogle Scholar
  40. Uhlmann EJ, Wong M, Baldwin RL, Bajenaru ML, Onda H, Kwiatkowski DJ, Yamada K, Gutmann DH. Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol. 2002;52:285–296.PubMedCrossRefGoogle Scholar
  41. van Slegtenhorst M, de Hoogt R, Hermans C, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science. 1997;277:805–8.PubMedCrossRefGoogle Scholar
  42. Waltereit R, Japs B, Schneider M, de Vries PJ, Bartsch D. Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats. Behav Genet. 2010.Google Scholar
  43. Way SW, McKenna 3rd J, Mietzsch U, et al. Loss of Tsc2 in radial glia models the brain pathology of tuberous sclerosis complex in the mouse. Hum Mol Genet. 2009;18:1252–65.PubMedCrossRefGoogle Scholar
  44. Weber AM, Egelhoff JC, McKellop JM, et al. Autism and the cerebellum: evidence from tuberous sclerosis. J Autism Dev Disord. 2000;30:511–17.PubMedCrossRefGoogle Scholar
  45. Whittemore VH. The history of tuberous sclerosis complex. In: Kwiatkowski DJ, Whittemore VH, Thiele EA, editors. Tuberous sclerosis complex. Weinheim: Wiley-VCH; 2010. p. 3–8.Google Scholar
  46. Young DM, Schenk AK, Yang SB, Jan YN, Jan LY. Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism. Proc Natl Acad Sci USA. 2010;107:11074–11079.PubMedCrossRefGoogle Scholar
  47. Zeng LH, Bero AW, Zhang B, et al. Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of tuberous sclerosis complex. Neurobiol Dis. 2010;37:764–71.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  1. 1.Department of NeurologyChildren’s Hospital Boston, Harvard Medical SchoolBostonUSA

Personalised recommendations